Insufficient scRNA-seq data for expression of MAGEA3 at single-cell level.
Insufficient scRNA-seq data for expression of MAGEA3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ureter | 0% | 0 | 0 / 0 | 100% | 51.70 | 1 / 1 |
skin | 0% | 0.03 | 1 / 1809 | 57% | 61.18 | 271 / 472 |
esophagus | 0% | 0.07 | 2 / 1445 | 38% | 32.99 | 70 / 183 |
lung | 0% | 0 | 0 / 578 | 31% | 30.98 | 356 / 1155 |
bladder | 0% | 0 | 0 / 21 | 30% | 27.57 | 149 / 504 |
stomach | 0% | 0 | 0 / 359 | 22% | 18.54 | 63 / 286 |
liver | 0% | 0 | 0 / 226 | 22% | 16.02 | 88 / 406 |
intestine | 0% | 0 | 0 / 966 | 14% | 15.53 | 74 / 527 |
uterus | 0% | 0 | 0 / 170 | 13% | 15.39 | 58 / 459 |
tonsil | 0% | 0 | 0 / 0 | 11% | 6.03 | 5 / 45 |
breast | 0% | 0 | 0 / 459 | 9% | 8.22 | 100 / 1118 |
pancreas | 0% | 0 | 0 / 328 | 6% | 4.65 | 11 / 178 |
prostate | 1% | 0.36 | 2 / 245 | 2% | 0.41 | 9 / 502 |
adrenal gland | 0% | 0 | 0 / 258 | 2% | 1.31 | 5 / 230 |
ovary | 0% | 0 | 0 / 180 | 2% | 0.58 | 9 / 430 |
kidney | 0% | 0 | 0 / 89 | 1% | 0.57 | 11 / 901 |
muscle | 0% | 0.17 | 3 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.25 | 3 / 929 | 0% | 0 | 0 / 0 |
thymus | 0% | 0.17 | 2 / 653 | 0% | 0 | 0 / 605 |
brain | 0% | 0.08 | 4 / 2642 | 0% | 0.08 | 1 / 705 |
adipose | 0% | 0.26 | 1 / 1204 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
GO_0043154 | Biological process | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0010507 | Biological process | negative regulation of autophagy |
GO_0010955 | Biological process | negative regulation of protein processing |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_1902236 | Biological process | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005634 | Cellular component | nucleus |
GO_0089720 | Molecular function | caspase binding |
GO_0005515 | Molecular function | protein binding |
GO_0042826 | Molecular function | histone deacetylase binding |
Gene name | MAGEA3 |
Protein name | Melanoma-associated antigen 3 (Antigen MZ2-D) (Cancer/testis antigen 1.3) (CT1.3) (MAGE-3 antigen) MAGE family member A3 |
Synonyms | MAGE3 |
Description | FUNCTION: Activator of ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases that acts as a repressor of autophagy . May enhance ubiquitin ligase activity of TRIM28 and stimulate p53/TP53 ubiquitination by TRIM28. Proposed to act through recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at the E3:substrate complex . May play a role in embryonal development and tumor transformation or aspects of tumor progression . In vitro promotes cell viability in melanoma cell lines . Antigen recognized on a melanoma by autologous cytolytic T-lymphocytes . . |
Accessions | P43357 ENST00000598245.2 ENST00000417212.5 ENST00000709974.1 E7EMU0 ENST00000370278.4 ENST00000709975.1 |